Conmed Corp (NYSE:CNMD)
$ 74.86 -0.45 (-0.6%) Market Cap: 2.31 Bil Enterprise Value: 3.28 Bil PE Ratio: 28.68 PB Ratio: 2.70 GF Score: 77/100

Conmed Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 09:15PM GMT
Release Date Price: $94.45 (-4.84%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

All right, thanks, everyone, for joining us today. I'm Drew Ranieri, a member of the medtech team here. It's my pleasure to have Curt Hartman and Todd Garner, the CEO and CFO of CONMED. Before we kind of jump into Q&A, just our quick disclaimer, but for important disclosures, please see Morgan Stanley Research disclosure's website. And if you have any questions, just reach out to your Morgan Stanley sales rep.

Questions & Answers

Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

But again, pleasure Curt and Todd to have you with us today. And we kind of started some of these conversations really kind of on the macro standpoint. And just as we've kind of heard through the past couple of days and even last week, it sounds like from a procedure volume perspective that things have slowed down in June, July and then improved in August and even into September. But we would kind of love to hear your views on that from a sports medicines perspective

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot